Clinical Report: Evaluating the Prognostic Significance of Glycemic Variability Metrics
Overview
This meta-analysis evaluates the relationship between various glycemic variability (GV) metrics and clinical outcomes in critically ill patients. It finds that elevated coefficients of variation (CV) and mean amplitude of glycemic excursions (MAGE) are associated with increased all-cause mortality and major adverse cardiovascular events.
Background
Glycemic variability is an important factor influencing prognosis in critically ill patients, particularly those experiencing stress-induced hyperglycemia.
Data Highlights
GV Metric
Association with ACM
Association with MACE
Coefficient of Variation (CV)
HR = 1.40 for NDM, HR = 1.32 for DM
HR = 2.45
Mean Amplitude of Glycemic Excursions (MAGE)
HR = 1.50
HR = 2.12
Standard Deviation (SD)
Not specified
HR = 2.45
Key Findings
Elevated CV is associated with increased 30-day, 90-day, and 1-year all-cause mortality.
MAGE shows the strongest association with 30-day all-cause mortality (HR = 1.50).
Both elevated SD and MAGE are linked to an increased risk of major adverse cardiovascular events (MACE).
The impact of increased CV on 30-day ACM is greater in non-diabetic patients compared to diabetic patients.
Clinical Implications
Clinicians should prioritize monitoring glycemic variability metrics, particularly MAGE and CV, to better predict patient outcomes in critically ill populations. Individualized glucose management strategies may enhance patient care and reduce mortality risks.
Conclusion
This study highlights the prognostic significance of glycemic variability metrics in critically ill patients.
